(19)
(11) EP 4 824 239 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24905013.9

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C12N 5/10(2006.01)
C12N 15/11(2006.01)
A61P 9/10(2006.01)
C12N 15/90(2006.01)
A61K 48/00(2006.01)
C12N 9/22(2006.01)
C12N 15/113(2010.01)
C07K 14/47(2006.01)
C12N 5/00(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/10; C12N 15/113; C12N 15/90; C12N 2750/14143; A61K 48/005; C12N 9/226; C12N 2310/20; C12N 2320/34; C12N 5/0657; C12N 2501/33; C12N 2501/415; C12N 2510/00; C12N 2506/45
(86) International application number:
PCT/US2024/060165
(87) International publication number:
WO 2025/129095 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610306 P

(71) Applicant: Tenaya Therapeutics, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • PRIEST, James Rush
    South San Francisco, California 94080 (US)
  • HOEY, Timothy C.
    South San Francisco, California 94080 (US)

(74) Representative: Goodwin Procter (UK) LLP 
Sancroft, 10-15 Newgate Street
EC1A 7AZ / London
EC1A 7AZ / London (GB)

   


(54) COMPOSITIONS AND METHODS FOR ALLELE-SPECIFIC MYH7 GENE EDITING